Position in VTRS
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$2,551,153
+$567,156 QoQ
Shares Held
160,652
+9.4% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#234
of 1,020 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 26%
Shared 0%
None 74%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $43,567,425 across 30 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
56,839 | $9,579,645 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
16,741 | $9,070,776 | |
| 3 | ZTS |
Zoetis Inc.
|
66,412 | $4,772,366 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
167,856 | $2,690,731 | |
| 5 | VTRS |
Viatris Inc
This page
|
160,652 | $2,551,153 | |
| 6 | HLN |
Haleon plc
|
259,261 | $2,418,905 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
70,403 | $2,385,253 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
74,362 | $1,830,048 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,551,153 | 160,652 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $1,983,997 | 146,854 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,817,575 | 145,990 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,260,893 | 127,363 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $687,547 | 76,993 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $580,913 | 66,695 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,496,950 | 120,237 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,632,818 | 140,639 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,636,271 | 248,003 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,009,250 | 252,031 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,978,141 | 274,990 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $2,811,825 | 285,175 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,967,513 | 297,346 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,012,752 | 417,126 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $907,974 | 81,579 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $491,041 | 57,634 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $383,254 | 36,605 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $414,397 | 38,088 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $558,234 | 41,259 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $511,634 | 37,759 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $622,486 | 43,561 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $533,081 | 38,159 | Shares | Sole | 2021-08-10 | |
| 2020-12-31 | $869,892 | 46,419 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||